See also this year's filing and all EDGAR filings for this company.
PDF Report 0001157601_2020_Madrigal_Pharmaceuticals_INC.pdf
Logs
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 0.8942096935739066, 'aggregate_val': 391482000, 'exp_sum': 206673000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 21864000, 'ResearchAndDevelopmentExpense': 184809000, 'remainder_Expenses': 0}} |
Graph
Absolute values for 0001157601, Madrigal Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 440,197,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,184,000 |
| 3 | remainder_Assets | 675,000 |
| 4 | LiabilitiesCurrent | 25,130,000 |
| 5 | LiabilitiesNoncurrent | 361,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 22,648,000 |
| 9 | ResearchAndDevelopmentExpense | 72,324,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 11,024,000 |
| 13 | remainder_ComprehensiveNetIncome | 535,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 442,056,000 |
| 1 | Liabilities | 25,491,000 |
| 2 | Expenses | 94,972,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 416,565,000 |
| 5 | NetIncome | -83,948,000 |
| 6 | ComprehensiveNetIncome | -83,680,500 |
| 7 | BaseVar | 287,039,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.53 |
| 9 | EconomicCapitalRatio | 4.05 |
Edgar->Model Mapping
Feature Distribution
Change over Time
